News and Announcements
Viralytics (ASX:VLA) – Investor and Shareholder Presentation
- Published July 23, 2013 10:53AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Viralytics is an Australian Stock Exchange listed company developing a portfolio of Oncolytic viruses that have the potential not only to provide a more effective treatment of a range of cancers, but also a substantial improvement in patients quality of life. Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics’ headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia.
Viralytics lead product CAVATAK™ has now entered the global phase II stage of clinical trial development with recruitment ongoing for a Phase II trial, treating Late Stage Melanoma patients – the CALM study. Viralytics New Drug (IND) application was allowed by the USA FDA, enabling this trial to be commenced in the USA during 2011. The Phase II trial will investigate the effectiveness of intratumourally administered CAVATAK™ in the treatment of Late Stage Melanoma.
Download the latest Investor & Shareholder Presentation below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
